Metastin suppresses the motility and growth of CHO cells transfected with its receptor

Biochemical and Biophysical Research Communications

Volumn 286, Issue 5, 2001, Pages 958-963

  Hori, Akira ^a   Honda, Susumu ^a   Asada, Mari ^a   Ohtaki, Tetsuya ^a   Oda, Katsuaki ^a   Watanabe, Takuya ^a   Shintani, Yasushi ^a   Yamada, Takao ^a   Suenaga, Masato ^a   Kitada, Chieko ^a   Onda, Haruo ^a   Kurokawa, Tsutomu ^a   Nishimura, Osamu ^a   Fujino, Masahiko ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

KiSS 1; Metastin; Motility; OT7T175

Indexed keywords

AMINO ACID; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; METASTIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; CHO CELL; CONTROLLED STUDY; DNA TRANSFECTION; LUNG METASTASIS; MELANOMA B16; METASTASIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUPPRESSOR GENE;

EID: 0034806010     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5470     Document Type: Article

References (27)

1. Metastasis suppressor gene KiSS-1 encodes metastin, the peptide ligand of hOT7T175 orphan G protein-coupled receptor
2. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals
3. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
4. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display
5. Suppression of metastasis in human breast carcinoma M.D.A-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1
6. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation
7. Bio-organic synthesis of a newly isolated peptide metastin, metastasis suppressor gene KiSS-1 processing product
8. Critical factors in the biology of human cancer metastasis: Twenty-eight G. H. A. Clowes Memorial Award Lecture
9. The role of cancer cell motility in invasion
10. Tumor invasion and metastases - Role of the extracellular matrix: Rhoades Memorial Award Lecture
11. Integrins: Versatility, modulation, and signaling in cell adhesion
12. Integrins: A family of cell surface receptors
13. New perspectives in cell adhesion: RGD and integrins
14. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis
15. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
16. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13
17. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13
18. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
19. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
20. Intercellular signaling by lysophosphatidate
21. 32P]-ADP-ribosylation of Gi by lysophosphatidic acid (LPA) in wild-type and alpha 2C10 adrenoceptor-transfected Rat 1 fibroblasts
22. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites
23. Sphingosine-1-phosphate inhibits extracellular matrix protein-induced haptotactic motility but not adhesion of B16 mouse melanoma cells
24. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction
25. Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells
26. Sphingosine-1-phosphate inhibits haptotactic motility by overproduction of focal adhesion sites in B16 melanoma cells through EDG-induced activation of rho
27. Antihypertensive effects of a highly potent long-acting angiotensin II subtype-1-receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2′- (1H-tetrazol-5-yl)biphenyl4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats